Technology Development

Technology Development Grant (TDG)

The TDG is awarded annually and can provide up to $150,000 to advance later stage technologies, where the concept has been proven. This award is intended to add value to the technology to increase the probability of licensing to an established company or start-up. The application process begins by submitting a Letter of Intent (.doc). Successful applications are invited to submit a Full Proposal (.doc), as well as a brief presentation to an external advisory board. The grant can be used for:

  • Prototype development
  • Human clinical data
  • Pre-clinical package
  • Drug delivery
  • Large animal studies
  • Other advanced pre-commercial research

A minimum of 70 percent of the project will be performed by a contract research organization (CRO). The project must be completed within two years of the award date.

Eligibility

  • The application must be based on intellectual property (IP) developed at the Boston Children's Hospital with the rights assigned to Boston Children's Hospital. The principal investigator must be a Boston Children's Hospital employee.
  • For the application to be considered for evaluation, a complete invention disclosure must be on file with TIDO.
  • At least one patent application should be filed with USPTO on the technology prior to submission of the Letter of Intent (LOI). The patent strategy and commercialization path for the technology must be well defined.

Evaluation Criteria

Internal and external reviewers are based on the following criteria:

  • Medical need or research significance
  • Path to market
  • Alignment with hospital mission
  • Impact of grant
  • Technical feasibility
  • Freedom to operate
  • Stage of development

Guidelines for submission of the Letter of Intent

Guidelines for submission of Full Proposal and presentation

  • Selected applicants will be invited to submit the full proposal. Download the Full Proposal (.doc), and submit as indicated for the LOI.*
  • Prepare a brief 15 minute presentation for the external advisory board. It is recommended that applicants follow the presentation guidelines provided with the full proposal.
  • Applicants chosen to receive funding will prepare and submit a project plan.

*Considering that the evaluation and selection process will place a strong emphasis on the commercial potential of the proposed project, applicants are encouraged to contact the technology development fund (please see contact info below) to discuss the full proposal as well as the format and content of the presentation.

Schedule and Deadlines:

  • TDF circulates the request for proposal (RFP) on January 11, 2017.
  • The LOI is due by 5 p.m. on February 8, 2017.
  • The applicants receive feedback by April 2017.
  • The full proposal is due in late April 2017.
  • The final presentation slides are due May 2017.
  • The presentation to the advisory board: June 16th, 2017.
  • The funds will be disbursed on: to be announced.

Contact Information

For additional information, contact Carla Haslauer, PhD, Principal, and Monique Yoakim-Turk, Partner, Technology Development Fund at technology.development@childrens.harvard.edu, or at x41375.

Children's HospitalTerms and Conditions
Site Designed and Developed by Genuine